alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 4.26


 


ASSIGNMENT
AND ASSUMPTION AGREEMENT


 


Assignment
And Assumption Agreement (the “Assignment”),
made as of May  __, 2018, between cCAM Biotherapeutics Limited
(“Assignor”) and Famewave Ltd. (“Assignee”) and agreed
to by Tel Hashomer - Medical Research, Infrastructure and Services Ltd. (“Tel
Hashomer”) and Ramot at Tel Aviv University Ltd. (“Ramot”
and together with Tel Hashomner, “Licensor”).


 


W
I T N E S S E T H :


 


Whereas,
Assignor is a party to a certain Restated and Amended License Agreement dated April 16, 2012, as amended (the “Agreement”),
by and among Licensor and Assignor; and


 


Whereas,
Assignee has acquired from Assignor certain assets developed subject to the Agreement; and


 


Whereas,
Assignor and Assignee desire that Assignor assign all of Assignor’s
rights, title and interest in, to and under the Agreement to Assignee, and that Assignee assume all of Assignor’s obligations
and duties under the Agreement; and


 


Whereas,
Licensor is willing to consent to such assignment and assumption
on the terms and subject to the conditions set forth herein;


 


Now,
Therefore, in consideration of the mutual
covenants and conditions hereinafter set forth, the parties hereto agree as follows:


 


ARTICLE
I


ASSIGNMENT
OF RIGHTS; ASSUMPTION OF OBLIGATIONS


 


Section
1.1. Assignor hereby acknowledges that it has assigned to Assignee all of its rights, title and interest under the Agreement
and Assignee has accepted such assignment.


 


Section
1.2. Assignee hereby assumes and agrees to undertake and perform any and all obligations and duties of Assignor under the
Agreement.


 


ARTICLE
II


LICENSOR’S
CONSENT


 


Section
2.1. Licensor hereby consents and agrees to the assignment and assumption set forth in Article I hereof.


 






    


     


    

 


ARTICLE
III


MISCELLANEOUS


 


Section
3.1. Counterparts. This Assignment may be executed in multiple copies, each of which shall for all purposes bind the
parties, and each party hereby covenants and agrees to execute all duplicates or replacement counterparts of this Assignment as
may be required.


 


Section
3.2. Applicable Law. This Assignment shall be governed by and construed in accordance with the laws of the State of
New York, without giving effect to the conflicts of laws provisions thereof.


 


In
Witness Whereof, the parties have caused
this Assignment to be executed by their authorized officers as of the date first written above.


 


	cCAM
    Biotherapeutics Limited	 	Famewave
    Ltd.
	 	 	 
	By: 	                         	 	By: 	            
	 	Name:	 	 	Name:
	 	Title:	 	 	Title:
	 	 	 
	Tel
    Hashomer - Medical Research, Infrastructure and Services Ltd.	 	Ramot
    at Tel Aviv University Ltd.
	 	 	 
	By: 	          	 	By: 	         
	 	Name:	 	 	Name:
	 	Title:	 	 	Title:
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the
Quarterly Report of K-V Pharmaceutical Company (the Company) on Form 10-Q for the quarter ended December 31, 2010, as filed with the Securities and Exchange Commission (the Report), I, Thomas S. McHugh, Chief Financial
Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |                        
|-------------------- |  | -----------------------
|Date: March 31, 2011 |  | /s/ Thomas S. McHugh   
|                     |  | Thomas S. McHugh       
|                     |  | Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as our exhibit to the Quarterly Report on Form
10-Q and shall not be deemed to be considered filed as part of the Quarterly Report on Form 10-Q.
**Exhibit 23.2**

 

 

CONSENT OF DANIEL J. FORBUSH, CERTIFIED PUBLIC ACCOUNTANT

 

         I consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-117306) of SulphCo, Inc. of my report dated May 13, 2002, with respect to the financial statements of SulphCo, Inc. included in this Amendment No. 5 to Annual Report on Form 10-KSB for the period ending December 31, 2003.

 

Reno, Nevada

January 25, 2005

 

/s/ Daniel J. Forbush

 

 

----
#### CLIFTON v. CLIFTON

No. 182P82.

Case below: 56 N.C. App. 257.

Petition by defendant for discretionary review under G.S. 7A-31 denied 4 May 1982.
Case 1:06-cr-00518-SHS Document 101 Filed 07/29/2008 Page 1 of 6Case 1:06-cr-00518-SHS Document 101 Filed 07/29/2008 Page 2 of 6Case 1:06-cr-00518-SHS Document 101 Filed 07/29/2008 Page 3 of 6Case 1:06-cr-00518-SHS Document 101 Filed 07/29/2008 Page 4 of 6Case 1:06-cr-00518-SHS Document 101 Filed 07/29/2008 Page 5 of 6Case 1:06-cr-00518-SHS Document 101 Filed 07/29/2008 Page 6 of 6
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     Ths schedule contains summary financial  information extracted from Keytone
Consolidated  Industries,  Inc.'s consolidated financial statements for the nine
months ended September 30, 1999 and is qualified in its entirety by reference to
such.
</LEGEND>


<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                            DEC-31-1999
<PERIOD-END>                                 Sep-30-1999
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                   40,340
<ALLOWANCES>                                     1,715
<INVENTORY>                                     62,279
<CURRENT-ASSETS>                               118,895
<PP&E>                                         355,372
<DEPRECIATION>                                 204,841
<TOTAL-ASSETS>                                 411,142
<CURRENT-LIABILITIES>                          124,004
<BONDS>                                        100,899
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,656
<OTHER-SE>                                      41,156
<TOTAL-LIABILITY-AND-EQUITY>                   411,142
<SALES>                                        277,379
<TOTAL-REVENUES>                               278,019
<CGS>                                          253,373
<TOTAL-COSTS>                                  253,373
<OTHER-EXPENSES>                                20,287
<LOSS-PROVISION>                               (2,954)
<INTEREST-EXPENSE>                              10,552
<INCOME-PRETAX>                                (3,248)
<INCOME-TAX>                                   (1,288)
<INCOME-CONTINUING>                            (1,987)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,987)
<EPS-BASIC>                                      (.20)
<EPS-DILUTED>                                    (.20)



</TABLE>
#### WATERS v. PERSONNEL, INC.

No. 111 PC.

Case below: 32 N.C. App. 548.

Petition by plaintiff for discretionary review under G.S. 7A-31 allowed 13 June 1977.
rsls_Ex10_5


		
			Exhibit 10.5
		

		
			AMENDMENT TO CREDIT AGREEMENT
		

		
			 
		

		
			This Amendment (this “Amendment”), dated as of March 31, 2020, is entered into by and among ReShape Lifesciences Inc., a Delaware corporation (the “Borrower”), and Armistice Capital Master Fund Ltd. (the “Lender”).  
		

		
			WHEREAS, the Borrower and the Lender entered into a Credit Agreement dated as of March 25, 2020 (the “Agreement”).
		

		
			WHEREAS, pursuant to Section 9.1(a) of the Agreement, the Agreement may be amended with the written consent of the Borrower and the Lender.
		

		
			WHEREAS, capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Agreement.
		

		
			NOW THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties agree as follows:
		

			
	
			
				 1.
			Amendment of Section 4.1.1 of the Agreement. Section 4.1.1 (Fees)  of the Agreement is hereby amended and restated in its entirety to read as follows:




		
			“Borrower shall have paid all fees, reasonable costs and reasonable out-of-pocket expenses, due and payable under this Agreement and the other Loan Documents on the Closing Date.”
		

			
	
			
				 2.
			Amendment to Section 4.2 of the Agreement. Section 4.2 (Delayed Draw Term Loans) is hereby amended to add the following sentence at the end of such section:




		
			“On the date on which Lender makes any Delayed Draw Term Loan hereunder, Borrower shall pay all fees, reasonable costs and reasonable out-of-pocket expenses, due and payable under this Agreement and the other Loan Documents on such date.”
		

			
	
			
				 3.
			Miscellaneous.  Except as expressly set forth hereunder, the terms and provisions of the Agreement shall remain in full force and effect after the execution of this Amendment and shall not be in any way changed, modified or superseded by the terms set forth herein.  This Amendment may be executed in several identical counterparts all of which shall constitute one and the same instrument.




		
			(Signature Page Follows)
		

		
			


		 





		

		
			IN WITNESS WHEREOF, the parties hereto have caused this Amendment to Credit Agreement to be duly executed as of the day and year written above.
		

		
			 
		

		
			 
		

			
					
						 

					
						BORROWER:

					
						 

					
						RESHAPE LIFESCIENCES INC.

					
						 

					
						By: /s/ barton p. bandy 

					
						Name: Barton P. Bandy

					
						Title: Chief Executive Officer

					
					
						 

					
						LENDER:

					
						 

					
						ARMISTICE CAPITAL MASTER FUND LTD.

					
						 

					
						By: /s/ steven boyd

					
						Name: Steven Boyd

					
						Title: CIO of Armistice Capital, LLC, the Investment Manager
<TABLE> <S> <C>

<ARTICLE> 7
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF LIBERTY CORPORATION FOR THE THREE MONTHS ENDED MARCH
31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<DEBT-HELD-FOR-SALE>                         1,723,967
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                      75,145
<MORTGAGE>                                     246,352
<REAL-ESTATE>                                   48,145
<TOTAL-INVEST>                               2,212,318
<CASH>                                          23,974
<RECOVER-REINSURE>                             282,234
<DEFERRED-ACQUISITION>                         340,099
<TOTAL-ASSETS>                               3,193,763
<POLICY-LOSSES>                              1,899,547
<UNEARNED-PREMIUMS>                                  0
<POLICY-OTHER>                                  36,581
<POLICY-HOLDER-FUNDS>                           28,623
<NOTES-PAYABLE>                                314,074
<PREFERRED-MANDATORY>                           26,605
<PREFERRED>                                     20,999
<COMMON>                                        68,908
<OTHER-SE>                                     465,937
<TOTAL-LIABILITY-AND-EQUITY>                 3,193,763
<PREMIUMS>                                      87,982
<INVESTMENT-INCOME>                             40,892
<INVESTMENT-GAINS>                               3,129
<OTHER-INCOME>                                  36,519
<BENEFITS>                                      57,106
<UNDERWRITING-AMORTIZATION>                     12,446
<UNDERWRITING-OTHER>                            40,689
<INCOME-PRETAX>                                 11,353
<INCOME-TAX>                                    13,776
<INCOME-CONTINUING>                             (2,423)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (2,423)
<EPS-PRIMARY>                                     (.15)
<EPS-DILUTED>                                     (.15)
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
Case 1:07-cv-03462-JFK Document 28 Filed 05/07/2008 Page 1 of 1
UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLUMBIA

RYAN BAGWELL,

Plaintiff, 

v. 

UNITED STATES DEPARTMENT OF 

JUSTICE,

Defendant. 

Case No. 15-cv-00531 (CRC)

ORDER

Having considered the Defendant’s [19] February 29, 2016 status report and supplemental 

Vaughn Index, the Court finds that the Department of Justice has adequately justified its 

withholding in full of the 104 previously withheld pages of documents as to which the Court 

reserved judgment in its December 18, 2015 Memorandum Opinion. See Bagwell v. U.S. Dep’t of 

Justice, No. 15-CV-00531 (CRC), 2015 WL 9272836, at *1 (D.D.C. Dec. 18, 2015). The 

combination of the supplemental Vaughn Index and the original affidavits also lead the Court to 

find that DOJ has released all reasonably segregable material in those documents. Therefore, it is 

hereby

ORDERED that Defendant’s [12] Motion for Summary Judgment be GRANTED IN 

PART with respect to those documents. It is further

ORDERED that Defendant’s [12] Motion for Summary Judgment be DENIED without 

prejudice in all other respects. It is further

ORDERED that Plaintiff’s [13] Cross-Motion for Partial Summary Judgment be DENIED. 

It is further

ORDERED that [19] Defendant’s Motion to Stay be DENIED. It is further
ORDERED that any overall objection by Defendant to the burdensomeness of Plaintiff’s 

FOIA request be filed, in the form of a renewed motion for summary judgement (or partial 

summary judgment), by March 30, 2016. In this regard, the government is reminded of the 

guidance offered by the Court at the February 11, 2016 telephonic status conference regarding the 

adequacy of treating certain groups of self-evident grand jury materials on a categorical basis so as 

to avoid the need for page-by-page review. It is further

ORDERED that, absent any wholesale burdensomeness objection, Defendant begin 

processing the request (or any remaining part of the request not challenged as unduly burdensome) 

upon the payment of applicable processing and duplication fees. Defendant shall produce all nonexempt material on a monthly, rolling basis. Defendant shall complete the production and a 

Vaughn Index of any withheld material within six months of its commencement absent leave of the 

Court. The Court will set a schedule for further dispositive motions by either party at the 

conclusion of the production, as necessary. It is further

ORDERED that the parties jointly file a further status report every 60 days, beginning 

March 31, 2016. 

SO ORDERED.

CHRISTOPHER R. COOPER

United States District Judge

Date: March 3, 2016

2
**Exhibit 23.2**

Consent of Independent Registered Public Accounting Firm 

We consent to the incorporation by reference in the RegistrationStatement (Form S-8 No. 333-117890) pertaining to the Xicor, Inc. 1998 Employee Stock Purchase Plan, Xicor, Inc. 1990 Incentive and Non-incentive Stock Option Plan, Xicor, Inc. 1998 Nonstatutory Stock Option Plan, Xicor, Inc. 2002 Stock OptionPlan, Xicor, Inc. 2000 Director Option Plan, Xicor, Inc. 1995 Director Option Plan, (Form S-8 No. 333-88208) pertaining to the Elantec Semiconductor, Inc. 1983 Stock Option Plan, Elantec Semiconductor, Inc. 1994 Equity Incentive Plan, ElantecSemiconductor, Inc. 1995 Employee Stock Purchase Plan, Elantec Semiconductor, Inc. 1995 Equity Incentive Plan and Elantec Semiconductor, Inc. 2001 Equity Incentive Plan, (Form S-8 No. 333-31094) pertaining to the Intersil Corporation 1999Equity Compensation Plan and Intersil Corporation Employee Stock Purchase Plan, (Form S-8 No. 333-50718) pertaining to the SiCOM, Inc. 1985 Incentive Stock Option Plan, SiCOM, Inc. 1996 Equity Incentive Plan and Option Issued to Robert W.Putnam, (Form S-8 No. 333-50722) pertaining to the Employee Stock Option Plan of No Wires Needed B.V., (Form S-8 No. 333-65804) pertaining to the Intersil Corporation 1999 Equity Compensation Plan, (Form S-4 No. 333-35052) and (FormS-4 No. 333-46984) and in the related Prospectuses of Intersil Corporation of our report dated February 28, 2006, with respect to the consolidated financial statements and schedule of Intersil Corporation, included in this Annual Report(Form 10-K) for the year ended December 29, 2006. 

/s/ Ernst & Young LLP 

          Certified Public Accountants 

Fort Lauderdale, Florida 

February 26,2007
Presidential Documents

70989 

Federal Register 

Vol. 70, No. 225 

Wednesday, November 23, 2005 

Title 3— 

The President 

Proclamation 7964 of November 21, 2005 

National Family Week, 2005 

By the President of the United States of America 

A Proclamation 

Families give our society direction and purpose. During National Family 

Week, we celebrate the many contributions families make to our country. 

Throughout America’s history, families have been the foundation of our 

society and a source of stability and love for every generation. Strong families 

teach children to live moral lives and help us pass down the values that 

define a caring society. By nurturing a child’s personal development and 

providing a safe environment for growth, families prepare our Nation’s youth 

to realize the promise of America. Family is one of the three cornerstones 

of the Helping America’s Youth initiative, led by First Lady Laura Bush. 

We are working with families, schools, and communities to help children 

make right choices and build healthy, successful lives. Through USA Freedom Corps, my Administration is also providing opportunities for families 

to volunteer together and make a positive difference in their communities. 

At this crucial hour in the history of freedom, our Nation is grateful for 

the sacrifice of our military families who love and support the men and 

women of our Armed Forces. My Administration is committed to providing 

a better quality of life for our military families and helping them plan 

for the future. During National Family Week and throughout the year, Americans stand solidly behind the men and women of our Armed Forces and 

join all military families as they pray for the safety and strength of their 

sons and daughters, husbands and wives, and fathers and mothers. 

NOW, THEREFORE, I, GEORGE W. BUSH, President of the United States 

of America, by virtue of the authority vested in me by the Constitution 

and laws of the United States, do hereby proclaim November 20 through 

November 26, 2005, as National Family Week. I invite the States, communities, and all the people of the United States to join together in observing 

this week with appropriate ceremonies and activities to honor our Nation’s 

families. 

IN WITNESS WHEREOF, I have hereunto set my hand this twenty-first 

day of November, in the year of our Lord two thousand five, and of the 

Independence of the United States of America the two hundred and thirtieth. 

W 

[FR Doc. 05–23332 

Filed 11–22–05; 11:59 am] 

Billing code 3195–01–P
**Exhibit 23**

 

**CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM**

 

We have issued our report dated March 14, 2005 accompanying the consolidated financial statements included in the Annual Report of Vision Bancshares, Inc.on Form 10-KSB for the year ended December 31, 2004. We hereby consent to the incorporation by reference of said report in the Registration Statements of Vision Bancshares, Inc. on Form S-8, effective October 31, 2003 (file no. 333-110133), on FormS-8, effective October 31, 2003 (file no. 333-110134), and on Form S-8, effective October 31, 2003 (file no. 333-110137). 

 

Atlanta, Georgia 

March 30, 2005 

 

MAULDIN & JENKINS, LLC 

 

/s/ MAULDIN & JENKINS, LLC
IN THE SUPREME COURT OF TEXAS

- - - - - - - -

NO. 16-0035

IN THE INTEREST OF M.A.M., A

CHILD §

§

§

§

§

§ Dallas County,

5th District.

February 26, 2016

Petitioner's petition for review, filed herein in the above numbered and styled case,

having been duly considered, is ordered, and hereby is, denied.

         

I, BLAKE A. HAWTHORNE

, Clerk of the Supreme Court of Texas, do hereby certify

that the above and attached is a true and correct copy of the orders of the Supreme Court of

Texas in the case numbered and styled as above, as the same appear of record in the minutes of

said Court under the date shown.

It is further ordered that petitioner, IN THE INTEREST OF M.A.M., A CHILD, pay all

costs incurred on this petition.

WITNESS my hand and seal of the Supreme Court of Texas, at the City of Austin, this

the 7th day of April, 2016

.

Blake A. Hawthorne, Clerk

By Monica Zamarripa, Deputy Clerk
#### CHURCH v. STATE

No. 119. PC.

No. 77 (Fall Term).

Case below: 40 N.C. App. 429.

Petition by Attorney General for discretionary review under G.S. 7A-31 arid notice of appeal allowed 12 July 1979.
Case 1:07-cv-03580-DLC     Document 7      Filed 05/22/2007     Page 1 of 1